Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Carlyle
Pharma
Gilead secures $210M from Abingworth to fund Trodelvy trials
Abingworth will offer Gilead up to $210 million to support select clinical studies of Trodelvy in non-small cell lung cancer.
Angus Liu
Feb 29, 2024 10:31am
CDMO Piramal earmarks $74M for upgrades to UK facilities
Feb 8, 2022 9:55am
Investor groups size up $25B bid for Sandoz: report
Feb 1, 2022 11:04am
Vectura at center of tug-of-war between Carlyle, Philip Morris
Aug 11, 2021 9:24am
Vectura has a new bidder in Marlboro maker Philip Morris
Jul 9, 2021 8:12am
Carlyle is buying British inhaled meds CDMO Vectura for $1.4B
May 26, 2021 8:57am
